Physician Wealth Advisors’s Coca-Cola Europacific Partners CCEP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.4K Buy
171
+22
+15% +$2.33K ﹤0.01% 734
2026
Q2
$14.9K Buy
149
+11
+8% +$1.05K ﹤0.01% 766
2026
Q1
$12.5K Buy
138
+7
+5% +$672 ﹤0.01% 738
2025
Q4
$11.9K Hold
131
– – ﹤0.01% 722
2025
Q3
$11.8K Sell
131
-12
-8% -$1.11K ﹤0.01% 715
2025
Q2
$13.3K Buy
143
+12
+9% +$1.08K ﹤0.01% 598
2025
Q1
$11.4K Hold
131
– – ﹤0.01% 596
2024
Q4
$10.1K Buy
+131
New +$10.1K ﹤0.01% 629

Other funds holding CCEP

Physician Wealth Advisors's CCEP Position: Q3 2026 in Review

Physician Wealth Advisors increased its Coca-Cola Europacific Partners (CCEP) stake by 15% in Q3 2026, buying an estimated $2.33K and bringing the position to 171 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #734.

Physician Wealth Advisors first reported a position in CCEP in Q4 2024 and has held it in 8 quarters since. 483 funds tracked by Wall St. Rank hold CCEP as of Q3 2026.

  • Physician Wealth Advisors held 171 shares of Coca-Cola Europacific Partners worth $17.4K as of Q3 2026.
  • Physician Wealth Advisors bought 22 Coca-Cola Europacific Partners shares in Q3 2026, an estimated $2.33K.
  • Coca-Cola Europacific Partners made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #734 holding.
  • Physician Wealth Advisors first reported a position in Coca-Cola Europacific Partners in Q4 2024 and has held it in 8 quarters since.
  • 483 funds tracked by Wall St. Rank held Coca-Cola Europacific Partners as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.